5
• Avoid placement or securement of the catheter where kinking may occur to minimize
stress on the catheter, patency problems or patient discomfort.
• Placement of the PowerMidline™ Catheter above antecubital fossa is recommended.
• Do not advance the guidewire past the axilla.
• The midline catheter tip location should be at or near the axillary line [INS, 2016].
• Catheter stylet must be wetted prior to stylet repositioning or withdrawal.
• The catheter must be secured in place to minimize risk of catheter breakage and embo-
lization.
• Do not allow accidental device contact with sharp instruments. Mechanical damage
may occur. Use only smooth edged, atraumatic clamps or forceps.
• Do not bend catheter at sharp angles during implantation. This can compromise cathe-
ter patency.
• When using peel-apart introducers:
- Avoid blood vessel damage by maintaining a catheter or dilator as internal
support when using a peel-apart introducer.
- Avoid sheath damage by simultaneously advancing the sheath and dilator as a
single unit using a rotational motion.
- Do not pull apart the portion of the sheath that remains in the vessel. To avoid
vessel damage, pull back the sheath as far as possible and tear the sheath only
a few centimeters at a time.
- Do not withdraw dilator from microintroducer sheath until sheath is within vessel
to minimize the risk of damage to sheath tip.
• Do not suture through or around any part of the catheter’s tubing (shaft or extension
legs). If using sutures to secure catheter USE THE SUTURE WINGS and make sure
they do not occlude, puncture, or cut the catheter.
• Do not use scissors to remove dressing to minimize the risk of cutting catheter.
• Accessories and components used in conjunction with this device should incorporate
luer lock connections. Do not over tighten the luer connector.
• Consider alternate placement site when there has been:
- Past irradiation of prospective insertion site.
- Previous episodes of venous thrombosis or vascular surgical procedures at the
prospective placement site.
Special Patient Population
NOTE:
(Pediatric) Insertion of midlines in pediatric patients may require the use of acces-
sories or components not included in this kit configuration, based on the size and devel
-
opmental age of the child and facility protocol. Follow the drug manufacturer’s recommen-
dations regarding use of any drugs or medications such as chlorhexidine prep solutions,
lidocaine injections and heparin flush solutions.
NOTE:
(Pediatric) “Site selection for vascular access shall include: Assessment of patient’s
condition; age; diagnosis; comorbidities; condition of the vasculature at the insertion site
and proximal to the intended insertion site; condition of skin at intended insertion site; his-
tory of previous venipunctures and access devices; type and duration of infusion therapy;
patient preference for VAD site selection.” In addition, facility policies, procedures, and/or
practice guidelines can be used to access proper site selection. [INS, 2016]
Содержание PowerMidline
Страница 1: ...1 Instructions For Use BARD...
